eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
4/2009
vol. 8
 
Share:
Send email
Share:
abstract:
Review paper

The hypoxic cell a target for selective cancer therapy

Bogdan Michalski
,
Anna Banyś
,
Agnieszka Drosdzol
,
Violetta Skrzypulec
,
Urszula Mazurek

Przegląd Menopauzalny 2009; 4: 196-201
Online publish date: 2009/09/07
View full text Get citation
 
Hypoxia is an unfavourable factor which predisposes both to more aggressive disease course and frequent metastases as well as patients’ resistance to standard therapy procedures. The development of neoplasm is dependent on oxygen amount and nutritive products supplied by the new blood vessels’ network (angiogenesis) with following direct distant metastases formation by new lymphatic vessels (lymphangiogenesis). This statement constitutes a paradigm. Hypoxia is a pathophysiological factor for angiogenesis and lymphangiogenesis in the neoplastic tumor. According to the latest clinical research, it was confirmed that hypoxia is a fundamental problem in radiotherapy and low cell’s oxygen saturation accelerates neoplasm progression in spite of the cancer therapy used. Hypoxia might cause drug-resistance through the amplification of specific genes as well as the induction of stress-proteins related to hypoxia.
keywords:

hypoxia, angiogenesis, HIF – hypoxia inducible factor, apoptosis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.